ropinirole has been researched along with sulpiride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Eden, RJ; Owen, DA; Patel, B; Wallduck, MS | 1 |
Luan, YW; Tang, DL; Xiao, C; Zhou, CY | 1 |
3 other study(ies) available for ropinirole and sulpiride
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Autonomic and haemodynamic responses to SK & F 101468 (ropinirole), a DA2 agonist, in anaesthetised cats.
Topics: Acetylcholine; Anesthesia; Animals; Autonomic Nervous System; Blood Pressure; Cats; Coronary Circulation; Dopamine Agents; Electric Stimulation; Female; Heart Rate; Hemodynamics; Indoles; Isoproterenol; Male; Sulpiride; Vagus Nerve; Vascular Resistance | 1990 |
D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice.
Topics: Action Potentials; Animals; Chronic Pain; Dopamine Agonists; Dopamine Antagonists; Indoles; Male; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinsonian Disorders; Patch-Clamp Techniques; Posterior Horn Cells; Receptors, Dopamine D2; Spinal Cord; Sulpiride | 2021 |